Search Results - "Fabri, Louis"

Refine Results
  1. 1

    The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs by Vietheer, Patricia T., Boo, Irene, Gu, Jun, McCaffrey, Kathleen, Edwards, Stirling, Owczarek, Catherine, Hardy, Matthew P., Fabri, Louis, Center, Rob J., Poumbourios, Pantelis, Drummer, Heidi E.

    Published in Hepatology (Baltimore, Md.) (01-04-2017)
    “…A vaccine that prevents hepatitis C virus (HCV) infection is urgently needed to support an emerging global elimination program. However, vaccine development…”
    Get full text
    Journal Article
  2. 2

    Engineering Stabilized Vascular Endothelial Growth Factor-A Antagonists: Synthesis, Structural Characterization, and Bioactivity of Grafted Analogues of Cyclotides by Gunasekera, Sunithi, Foley, Fiona M, Clark, Richard J, Sando, Lillian, Fabri, Louis J, Craik, David J, Daly, Norelle L

    Published in Journal of medicinal chemistry (25-12-2008)
    “…Cyclotides are plant derived mini-proteins with compact folded structures and exceptional stability. Their stability derives from a head-to-tail cyclized…”
    Get full text
    Journal Article
  3. 3

    Scalability of Sartobind® Rapid A Membrane for High Productivity Monoclonal Antibody Capture by Yang, Sabrina, Braczkowski, Ryszard, Chen, Shih-Hsun, Busse, Ricarda, Li, Yudhi, Fabri, Louis, Bekard, Innocent Berbelle

    Published in Membranes (Basel) (27-09-2023)
    “…Improved upstream titres in therapeutic monoclonal antibody (mAb) production have shifted capacity constraints to the downstream process. The consideration of…”
    Get full text
    Journal Article
  4. 4

    One-step zero-background IgG reformatting of phage-displayed antibody fragments enabling rapid and high-throughput lead identification by Chen, Chao-Guang, Fabri, Louis J, Wilson, Michael J, Panousis, Con

    Published in Nucleic acids research (01-02-2014)
    “…We describe a novel cloning method, referred to as insert-tagged (InTag) positive selection, for the rapid one-step reformatting of phage-displayed antibody…”
    Get full text
    Journal Article
  5. 5

    EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE) by Munro, Kathryn M, Dixon, Kirsty J, Gresle, Melissa M, Jonas, Anna, Kemper, Dennis, Doherty, William, Fabri, Louis J, Owczarek, Catherine M, Pearse, Martin, Boyd, Andrew W, Kilpatrick, Trevor J, Butzkueven, Helmut, Turnley, Ann M

    Published in PloS one (04-02-2013)
    “…The EphA4 receptor tyrosine kinase is a major regulator of axonal growth and astrocyte reactivity and is a possible inflammatory mediator. Given that multiple…”
    Get full text
    Journal Article
  6. 6

    A robust robotic high-throughput antibody purification platform by Schmidt, Peter M., Abdo, Michael, Butcher, Rebecca E., Yap, Min-Yin, Scotney, Pierre D., Ramunno, Melanie L., Martin-Roussety, Genevieve, Owczarek, Catherine, Hardy, Matthew P., Chen, Chao-Guang, Fabri, Louis J.

    Published in Journal of Chromatography A (15-07-2016)
    “…•Two stage robust antibody purification platform has been established.•High yield preparative antibody purification for initial screening…”
    Get full text
    Journal Article
  7. 7

    Optimizing high throughput antibody purification by using continuous chromatography media by Butcher, Rebecca E., Martin-Roussety, Genevieve, Bradford, Rebecca A., Tester, Andrea, Owczarek, Catherine, Hardy, Matthew P., Chen, Chao-Guang, Sansome, Georgina, Fabri, Louis J., Schmidt, Peter M.

    Published in Protein expression and purification (01-07-2019)
    “…The ability to engineer monoclonal antibodies (mAbs) with high specificity made mAbs the fastest growing segment in the drug market. mAbs represent 8 of the…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Intravenous immunglobulin binds beta amyloid and modifies its aggregation, neurotoxicity and microglial phagocytosis in vitro by Cattepoel, Susann, Schaub, Alexander, Ender, Miriam, Gaida, Annette, Kropf, Alain, Guggisberg, Ursula, Nolte, Marc W, Fabri, Louis, Adlard, Paul A, Finkelstein, David I, Bolli, Reinhard, Miescher, Sylvia M

    Published in PloS one (16-05-2013)
    “…Intravenous Immunoglobulin (IVIG) has been proposed as a potential therapeutic for Alzheimer's disease (AD) and its efficacy is currently being tested in…”
    Get full text
    Journal Article
  13. 13
  14. 14

    SH2 Domains from Suppressor of Cytokine Signaling-3 and Protein Tyrosine Phosphatase SHP-2 Have Similar Binding Specificities by De Souza, David, Fabri, Louis J, Nash, Andrew, Hilton, Douglas J, Nicola, Nicos A, Baca, Manuel

    Published in Biochemistry (Easton) (23-07-2002)
    “…Suppressor of cytokine signaling-3 (SOCS-3) and the protein tyrosine phosphatase SHP-2 both regulate signaling by cytokines of the interleukin-6 family, and…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Crystal Structure of Vascular Endothelial Growth Factor-B in Complex with a Neutralising Antibody Fab Fragment by Leonard, Philip, Scotney, Pierre D., Jabeen, Talat, Iyer, Shalini, Fabri, Louis J., Nash, Andrew D., Acharya, K. Ravi

    Published in Journal of molecular biology (31-12-2008)
    “…Vascular endothelial growth factor (VEGF) B effects blood vessel formation by binding to VEGF receptor 1. To study the specifics of the biological profile of…”
    Get full text
    Journal Article
  17. 17

    Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain by Babon, Jeffrey J., Yao, Shenggen, DeSouza, David P., Harrison, Christopher F., Fabri, Louis J., Liepinsh, Edvards, Scrofani, Sergio D., Baca, Manuel, Norton, Raymond S.

    Published in The FEBS journal (01-12-2005)
    “…SOCS3 is a negative regulator of cytokine signalling that inhibits Janus kinase‐signal transduction and activator of transcription (JAK‐STAT) mediated signal…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Application of mechanistic modelling in membrane and fiber chromatography for purification of biotherapeutics — A review by Qu, Yiran, Baker, Irene, Black, Jamie, Fabri, Louis, Gras, Sally L., Lenhoff, Abraham M., Kentish, Sandra E.

    Published in Journal of Chromatography A (08-02-2024)
    “…•Mass transfer models for membrane and fiber chromatography are described.•Models can be less complicated than for resin chromatography.•Different flow paths…”
    Get full text
    Journal Article